Effect of berberine on hepatic glucokinase and its regulatory protein in insulin-resistant rats

World Chinese Journal of Digestology

Volumn 15, Issue 8, 2007, Pages 885-889

  Ouyang, Li Zhi ^a   Lu, Fu Er ^a   Liu, Wen Jun ^a   Gao, Zhi Qiang ^a   Xu, Li Jun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Berberine; Glucokinase; Glucokinase regulatory protein; Insulin resistance

Indexed keywords

BERBERINE; GLUCOKINASE; GLYCOGEN; LIVER ENZYME; METFORMIN; REGULATOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; GLYCOGEN LIVER LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

EID: 34249775812     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Chinese source
2. Chinese source
3. Chinese source
4. Pan LR, Tang Q, Fu Q, Hu BR, Xiang JZ, Qian JQ. Roles of nitric oxide in protective effect of berberine in ethanol-induced gastric ulcer mice. Acta Pharmacol Sin 2005; 26: 1334-1338
5. Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ, Shen Y, Ye JM, Lee CH, Oh WK, Kim CT, Hohnen-Behrens C, Gosby A, Kraegen EW, James DE, Kim JB. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 2006; 55: 2256-2264
6. Chinese source
7. Tang LQ, Wei W, Chen LM, Liu S. Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats. J Ethnopharmacol 2006; 108: 109-115
8. Storlien LH, James DE, Burleigh KM, Chisholm DJ, Kraegen EW. Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats. Am J Physiol 1986; 251: E576-E583
9. Petrik J, Srinivasan M, Aalinkeel R, Coukell S, Arany E, Patel MS, Hill DJ. A long-term high-carbohydrate diet causes an altered ontogeny of pancreatic islets of Langerhans in the neonatal rat. Pediatr Res 2001; 49: 84-92
10. Chinese source
11. Chinese source
12. Chinese source
13. Chinese source
14. Davidson AL, Arion WJ. Factors underlying significant underestimations of glucokinase activity in crude liver extracts: physiological implications of higher cellular activity. Arch Biochem Biophys 1987; 253: 156-167
15. Mendez-Sanchez N, Chavez-Tapia NC, Motola-Kuba D, Sanchez-Lara K, Ponciano-Rodriguez G, Baptista H, Ramos MH, Uribe M. Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol 2005; 11: 1653-1657
16. Chinese source
17. Mendez-Sanchez N, Bermejo-Martinez LB, Vinals Y, Chavez-Tapia NC, Graff IV, Ponciano-Rodriguez G, Ramos MH, Uribe M. Serum leptin levels and insulin resistance are associated with gallstone disease in overweight subjects. World J Gastroenterol 2005; 11: 6182-6187
18. Leng SH, Lu FE, Xu LJ. Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion. Acta Pharmacol Sin 2004; 25: 496-502
19. Chinese source
20. de la Iglesia N, Mukhtar M, Seoane J, Guinovart JJ, Agius L. The role of the regulatory protein of glucokinase in the glucose sensory mechanism of the hepatocyte. J Biol Chem 2000; 275: 10597-10603
21. Chinese source
22. Coope GJ, Atkinson AM, Allott C, McKerrecher D, Johnstone C, Pike KG, Holme PC, Vertigan H, Gill D, Coghlan MP, Leighton B. Predictive blood glucose lowering efficacy by Glucokinase activators in high fat fed female Zucker rats. Br J Pharmacol 2006; 149: 328-335
23. Veiga-da-Cunha M, Van Schaftingen E. Identification of fructose 6-phosphate- and fructose 1-phosphate-binding residues in the regulatory protein of glucokinase. J Biol Chem 2002; 277: 8466-8473
24. Slosberg ED, Desai UJ, Fanelli B, St Denny I, Connelly S, Kaleko M, Boettcher BR, Caplan SL. Treatment of type 2 diabetes by adenoviral-mediated overexpression of the glucokinase regulatory protein. Diabetes 2001; 50: 1813-1820